Morgan Stanley’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.55M Sell
5,987,541
-4,349,682
-42% -$2.58M ﹤0.01% 4338
2025
Q1
$9.06M Sell
10,337,223
-3,636,134
-26% -$3.19M ﹤0.01% 3430
2024
Q4
$23.6M Sell
13,973,357
-297,028
-2% -$502K ﹤0.01% 2595
2024
Q3
$27.4M Sell
14,270,385
-177,956
-1% -$342K ﹤0.01% 2473
2024
Q2
$35.5M Buy
14,448,341
+4,121,663
+40% +$10.1M ﹤0.01% 2072
2024
Q1
$16.9M Sell
10,326,678
-12,067,720
-54% -$19.8M ﹤0.01% 2873
2023
Q4
$39.9M Buy
22,394,398
+12,108,032
+118% +$21.6M ﹤0.01% 2692
2023
Q3
$47.1M Buy
10,286,366
+590,964
+6% +$2.71M ﹤0.01% 1637
2023
Q2
$108M Buy
9,695,402
+84,317
+0.9% +$944K 0.01% 1038
2023
Q1
$109M Sell
9,611,085
-1,336,410
-12% -$15.1M 0.01% 1010
2022
Q4
$75.1M Buy
10,947,495
+595,839
+6% +$4.09M 0.01% 1210
2022
Q3
$93.3M Buy
+10,351,656
New +$93.3M 0.01% 930
2022
Q1
Sell
-9,456
Closed -$94K 8081
2021
Q4
$94K Buy
9,456
+2,600
+38% +$25.8K ﹤0.01% 6484
2021
Q3
$67K Buy
+6,856
New +$67K ﹤0.01% 6584